Infection Control News

WASHINGTON — Some infants with in utero or early life exposure to SARS-CoV-2 had borderline to low developmental scores, a study found, and this was most common among babies born to mothers with symptomatic COVID-19.

Long COVID can cause multisystem health issues that can last anywhere from months to years. We asked Farha S. Ikramuddin, MD, MPH, assistant professor in the department of rehabilitation medicine at the University of Minnesota Medical School, what the most significant consequence of long COVID will be moving forward.

WASHINGTON — Since its start 25 years ago, the varicella vaccine program in the United States has led to high vaccination coverage, resulting in a 97% decrease in cases of the disease also known as chickenpox, according to data presented at IDWeek.

Early data from a phase 2/3 trial suggest that the new Pfizer and BioNTech omicron booster increases protective antibodies against the BA.5 subvariant in adults 7 days after administration.

Experts say that people with HIV should be included in clinical trials for new tuberculosis vaccine candidates in the pipeline, according to newly written recommendations published in The Lancet HIV.

Those who survive 30 days of SARS-CoV-2 infection have an increased risk for neurological disorders after 1 year compared with those who were not infected, according to a report in Nature Medicine.

Early data from trials assessing the new Pfizer and BioNTech omicron-adapted booster vaccine show that the vaccine substantially increased protective antibodies against the BA.5 subvariant in adults.

In a recent survey from the National Foundation for Infectious Diseases, less than half of adults in the United States said they plan to get the influenza vaccine this season.

ANAHEIM, Calif. — An antimicrobial stewardship initiative involving more than 130 U.S. hospitals has shown promise — particularly when it comes to treating children for an appropriate duration, researchers reported here.

Readmission within 30 days of discharge was common among survivors of COVID-19, and more so in those with comorbidities, researchers found.